Pierce A M AM - OmicsDI

Show results for

Unknown (275)
Proteomics (259)
Transcriptomics (9)
Metabolomics (8)
Genomics (5)

Organisms

Homo sapiens (137)
Mus musculus (62)
Rattus norvegicus (14)
Saccharomyces cerevisiae (7)
Escherichia coli (6)
Equus caballus (3)
Ovis aries (3)
502780 (2)
Bos taurus (2)
Crotalus durissus terrificus (2)
Drosophila melanogaster (2)
Gallus gallus (2)
Haemonchus contortus (2)
Sus scrofa domesticus (2)
Xenopus laevis (2)
Aplysia californica (1)
1423687 (1)
Amycolatopsis (1)
Bacillus subtilis (1)
Bacteria (1)
Cepaea nemoralis (1)
Chlamydomonas reinhardtii (1)
Enterococcus faecium ERV165 (1)
Fulmarus glacialis (1)
Methylobacillus flagellatus KT (1)
Papio anubis anubis (1)
Papio hamadryas adenovirus 1 (1)
Pseudomonas aeruginosa (1)
Pseudomonas aeruginosa PAO1 (1)
Schizosaccharomyces pombe 927 (1)

Repository

pride (255)
biostudies-arrayexpress (17)
MetaboLights (8)
MassIVE (1)

Tissue

Cell culture (49)
Epithelial cell (20)
Kidney (15)
Blood plasma (14)
Brain (12)
Liver (12)
Heart (11)
Lung (11)
Blood (8)
Blood cell (7)
Blood serum (5)
Cell suspension culture (5)
Fibroblast (5)
Permanent cell line cell (5)
Stem cell (5)
B cell (4)
Bone marrow (4)
HEK-293T cell (4)
Hepatocyte (4)
Macrophage (4)
Whole body (4)
Erythrocyte (3)
Reticulocyte (3)
T cell (3)
Breast (2)
Colon (2)
Early embryonic cell (2)
Egg (2)
Endothelium (2)
HUVEC cell (2)

Disease

Disease free (10)
Breast cancer (6)
Acute leukemia (3)
Type 2 diabetes mellitus (3)
Alzheimer's disease (2)
COVID-19 (2)
Cardiovascular system disease (2)
Cervix carcinoma (2)
Colon cancer (2)
Liver cancer (2)
Lung small cell carcinoma (2)
Paracoccidioidomycosis (2)
Locally advanced rectal cancer (1)
Normal (1)
Amyotrophic lateral sclerosis (1)
Autism spectrum disorder (1)
Autoimmune hepatitis (1)
Bacterial sepsis (1)
Brain glioblastoma multiforme (1)
Chronic kidney disease (1)
Chronic lymphocytic leukemia (1)
Colorectal cancer (1)
Cryptococcosis (1)
Diastolic heart failure (1)
Duchenne muscular dystrophy (1)
FTDALS1 (1)
Human immunodeficiency virus infectious disease (1)
Huntington Disease (1)
Marfan syndrome (1)
Neurodevelopmental delay (1)

Technology Type

Mass Spectrometry (255)
Shotgun proteomics (142)
Bottom-up proteomics (48)
Data-dependent acquisition (29)
Data-independent acquisition (20)
Gel-based experiment (19)
Affinity purification coupled with mass spectrometry proteomics (18)
Chemical cross-linking coupled with mass spectrometry proteomics (10)
SWATH MS (10)
Top-down proteomics (9)
Mass spectrometry (6)
All-ion fragmentation (3)
SRM/MRM (3)
Mass spectrometry assay (2)
Affinity proteomics (1)
DiaPASEF (1)
HDMSE (1)
MSE (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (3)
Exactive (Thermo Scientific) (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Illumina NovaSeq 6000 (1)
Q Exactive HF (1)
Direct infusion MS - positive (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (43)
2023 (39)
2024 (32)
2022 (32)
2026 (28)
2021 (23)
2020 (22)
2019 (20)
2018 (13)
2017 (11)
2013 (6)
2014 (4)
2016 (3)
2015 (2)
2012 (2)
2010 (1)

CHEBI ID

CHEBI:15741 (3)
CHEBI:17306 (3)
CHEBI:18050 (3)
CHEBI:84660 (3)
CHEBI:84661 (3)
CHEBI:84662 (3)
CHEBI:84665 (3)
CHEBI:85725 (3)
CHEBI:85726 (3)
CHEBI:85729 (3)
CHEBI:85734 (3)
CHEBI:85736 (3)
CHEBI:85740 (3)
CHEBI:85741 (3)
CHEBI:85753 (3)
CHEBI:85832 (3)
CHEBI:85871 (3)
CHEBI:85875 (3)
CHEBI:85876 (3)
CHEBI:10072 (2)
CHEBI:139272 (2)
CHEBI:15318 (2)
CHEBI:15414 (2)
CHEBI:15428 (2)
CHEBI:1547 (2)
CHEBI:15611 (2)
CHEBI:15676 (2)
CHEBI:15698 (2)
CHEBI:15721 (2)
CHEBI:15724 (2)

Metabolite Name

Adenine (3)
Creatine (3)
Creatinine (3)
L-Histidine (3)
L-Proline (3)
Tryptophan (3)
Uridine (3)
10-Hydroxydecanoic acid (2)
12-Hydroxydodecanoic acid (2)
2,4-Quinolinediol (2)
2-Methylhippuric acid (2)
2-Oxovaleric acid (2)
4-Acetamidobutanoic acid (2)
4-Pyridoxic acid (2)
5-Hydroxylysine (2)
5-Methyldeoxycytidine (2)
5-Sulfosalicylic acid (2)
7-Methylhypoxanthine (2)
Allantoin (2)
Avenic acid B (2)
Azelaic acid (2)
Benzoic acid (2)
Cholic acid (2)
Citric acid (2)
Cytosine (2)
Dihydroxyacetone phosphate (2)
Erythritol (2)
Glucose (2)
Hippuric acid (2)
Homovanillic acid (2)

Study type

ChIP-seq (4)
Transcription profiling by array (4)
Methylation profiling by array (3)
Proteomic profiling by array (3)
ChIP-chip by array (1)
Other (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2020 (35)
2022 (34)
2023 (25)
2017 (21)
2013 (20)
2015 (18)
2024 (18)
2021 (18)
2025 (16)
2016 (16)
2019 (13)
2018 (12)
2014 (10)
2012 (10)
2010 (8)
2011 (6)
2009 (6)
2026 (4)
2008 (1)
2007 (1)

Lab affiliation

Department of Biochemistry, Biomedical Sciences Building, University of Bristol, Bristol, United Kingdom (3)
Department of Biology, Institute of Microbiology, ETH Zürich, Switzerland (3)
Department of Cell Biology, Harvard Medical School, Boston, MA, USA (3)
Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (3)
Chemical and Biological Engineering, Hong Kong University of Science and Technology (HKUST) (2)
Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States (2)
Div. Clinical Protein Science and Imaging, Dept. of Clinical Sciences and Dept. of Biomedical Engineering, Lund University, Sweden (2)
Finley and Gygi lab Cell Biology Department Harvard Medical School US (2)
Foetal Exposure Group School of Clinical Sciences University of Bristol United Kingdom (2)
Functional Proteomics, ICR (2)
Goethe University Frankfurt, University Hospital, Clinic of Neurology, Experimental Neurology, Heinrich Hoffmann Str. 7, 60590 Frankfurt am Main, Germany (2)
Indiana University School of Medicine (2)
Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany. (2)
Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine, Lund, Sweden (2)
Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland (2)
Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 NeuchÃƒÂ¢tel, Switzerland (part of Philip Morris International group of companies) (2)
Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies) (2)
University of Cologne, Germany (2)
University of Michigan (2)
1. Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany 2. Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH93BF, United Kingdom (1)
1Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC, 3010, Australia 2Murdoch Children’s Research Institute, Melbourne, VIC 3052, Australia 3Victorian Clinical Genetics Services, Murdoch Children’s Research Institute, Melbourne, VIC, 3052, Australia (1)
1Nutrient Metabolism & Signalling Laboratory, Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia. 2Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Victoria 3800, Australia. (1)
95 Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, 31077, France (1)
Albert Einstein College of Medicine (1)
Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA (1)
Assistant Professor, Department of Chemistry, The ScrippsResearch Institute (1)
Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, United Kingdom (1)
Baker Heart & Diabetes Institute and Murdoch Childrens Research Institute (pmpf@unimelb.edu.au) (1)
Bioanalytical Mass Spectrometry, Max Planck Institute for Multidisciplinary Sciences, Am Faßberg 11, 37077 Göttingen, Germany (1)
Biochemistry, University of Colorado, Boulder (1)

Previous page
1 / 56
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 56
Next page

Sort by:

Relevance

Page size

An engineered innate immune defense protects grapevines from Pierce disease.

Not available

S-EPMC3309795 | biostudies-literature

Extracellular Vesicles from probiotics mediated Walnut green husk polysaccharide alleviates ochratoxin-A-induced cognitive impairment via SCFA and 5-HT mediated microbiota-gut-brain axis

BACKGROUND: Ochratoxin A (OTA) have made it a serious hazard to food safety worldwide that poses a serious health risk to humans. Our previous research showed that Walnut green husk polysaccharides (WGP) can effectively alleviate intestinal inflammation and intestinal microbiota ...

2024-10-10 | MTBLS10673 | MetaboLights

New Pathophysiological Insights from Serum Proteome Profiling in Equine Atypical Myopathy.

Equine atypical myopathy (AM) is a severe environmental intoxication linked to the ingestion of protoxins contained in seeds and seedlings of the sycamore maple (Acer pseudoplatanus) in Europe. The toxic metabolites cause a frequently fatal rhabdomyolysis syndrome in grazing horses. Since toxic meta...

ORGANISM(S): Equus caballus (Horse)

2024-02-09 | PXD040429 | Pride

A gp130-induced Src/Yes-YAP Cascade Links Inflammation to Regeneration in the Mammalian Intestine

gp130Act cDNA was PCR-amplified and inserted into a plasmid containing the 12.4-kb Villin promoter. The 15.7-kb expression cassette was excised by PmeI digestion, purified, and injected into fertilized C57BL/6 oocytes to obtain founder mice, two of which transmitted the gp130Act transgene. Small int...

ORGANISM(S): Mus musculus

2015-02-21 | E-MTAB-2400 | biostudies-arrayexpress

Proteome profiling of Akkermansia muciniphila, Bifidobacterium longum, and Bifidobacterium breve in different nutrient environments

To understand how glycans influence the growth of probiotic strains in monocultures and communities, we characterized the growth and perform proteome profiling of 3 major probiotics, A. muciniphila (AM) BAA-835, B. breve (BB) JCM1192, and B. longum (BL) JCM1217 in monocultures and co-cultures grown ...

ORGANISM(S): Akkermansia muciniphila ATCC BAA-835

2025-09-24 | PXD060954 | Pride

Arabinoxylan Bifidobacterium breve Co-culture Probiotics Bifidobacterium longum Akkermansia muciniphila Mucin

Proteome profiling of IEC-6 cells after treatment with Akkermansia muciniphila (AM), Bifidobacterium longum (BL), or AM-BL combination

To profile the proteome of intestinal epithelial IEC-6 cells in response to treatment with Akkermansia muciniphila, Bifidobacterium longum, or Akkermansia muciniphila + Bifidobacterium longum co-culture. In addition, we also add arabinoxylan (AX) to Akkermansia muciniphila + Bifidobacterium longum c...

ORGANISM(S): Rattus norvegicus (Rat)

2025-09-24 | PXD061633 | Pride

Iec-6 Akkermansia muciniphila Bifidobacterium longum Co-culture

Hif1α-Dependent Uncoupling Of Glycolysis Suppresses Tumor Cell Proliferation

Hypoxia-inducible factor-1α (HIF1α) attenuates mitochondrial activity while promoting glycolysis. Paradoxically, it remains unknown why lower glycolysis is compromised in human clear cell renal cell carcinomas (ccRCC), in which HIF1α acts a tumor suppressor by inhibiting cell autonomous proliferatio...

2024-03-15 | MTBLS8901 | MetaboLights

Comparing the plasma membrane proteins of Nek1+/+ and Nek1Kat2J/Kat2J MEFs

Mass spectrometry data comparing the plasma membrane proteins of Nek1-WT and Nek1-Kat2J MEFs enriched by Pierce™ Cell Surface Protein Isolation Kit.

ORGANISM(S): Mus musculus (Mouse)

2021-08-06 | PXD027493 | Pride

Nek1 Plasma membrane proteins Retromer

The Hippo tranducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation

The Hippo pathway effector YAP1 controls stem cell fate in epithelial tissues, but its role in stem cells of non-epithelial tissues, such as skeletal muscle, is poorly documented. Here we show that sustained YAP1 activity in mouse activated satellite cells in vivo induces rhabdomyosarcoma (RMS) rese...

ORGANISM(S): Homo sapiens

2014-08-12 | E-GEOD-55186 | biostudies-arrayexpress

Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes.